Half-year report · HY
3840.TEDINET S100X3IZ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥323m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥84m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥324m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥229m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥78m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥321m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥79m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥647m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥777m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥98m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥155m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥98m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥190m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥182m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥539m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥248m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥199m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥525m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥324m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥573m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.25 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥74m |
| AI Technologyreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥67m |
| Beauty And Wellness Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥39m |
| Cosmetics Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥84m |
| Investment Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥18m |
| Market Expansion Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥50,000 |
| Market Expansion Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥21m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥258m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥254m |
| Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥26m |
| Sustainable Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥30m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | −¥249m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥58m |
| Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| Sustainable Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥29m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥26m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 527
| Item | Context | Value | Unit |
|---|---|---|---|
| Subsidy income noi bounty | Prior1InterimDuration | 4996000 | JPY |
| Subsidy income noi bounty | InterimDuration | 2000000 | JPY |
| Other noi | Prior1InterimDuration | 2440000 | JPY |
| Other noi | InterimDuration | 1376000 | JPY |
| Non operating income | Prior1InterimDuration | 8053000 | JPY |
| Non operating income | InterimDuration | 4088000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 1211000 | JPY |
| Interest expenses noe | InterimDuration | 3462000 | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 2000 | JPY |
| Foreign exchange losses noe | InterimDuration | － | JPY |
| Stock issuance cost noe | Prior1InterimDuration | 562000 | JPY |
| Stock issuance cost noe | InterimDuration | 740000 | JPY |
| Other noe | Prior1InterimDuration | 145000 | JPY |
| Other noe | InterimDuration | 1041000 | JPY |
| Non operating expenses | Prior1InterimDuration | 1921000 | JPY |
| Non operating expenses | InterimDuration | 5244000 | JPY |
| Ordinary income | Prior1InterimDuration | -77978000 | JPY |
| Ordinary income | InterimDuration | -323989000 | JPY |
| Gain on reversal of subscription rights to shares ei | Prior1InterimDuration | － | JPY |
| Gain on reversal of subscription rights to shares ei | InterimDuration | 3376000 | JPY |
| Extraordinary income | Prior1InterimDuration | － | JPY |
| Extraordinary income | InterimDuration | 3376000 | JPY |
| Impairment loss el | Prior1InterimDuration | 1125000 | JPY |
| Impairment loss el | InterimDuration | － | JPY |
| Extraordinary loss | Prior1InterimDuration | 1125000 | JPY |
| Extraordinary loss | InterimDuration | － | JPY |
| Income before income taxes | Prior1InterimDuration | -79103000 | JPY |
| Income before income taxes | InterimDuration | -320612000 | JPY |
| Income taxes current | Prior1InterimDuration | 2475000 | JPY |
| Income taxes current | InterimDuration | 1278000 | JPY |
| Income taxes deferred | Prior1InterimDuration | -30000 | JPY |
| Income taxes deferred | InterimDuration | -1831000 | JPY |
| Income taxes | Prior1InterimDuration | 2444000 | JPY |
| Income taxes | InterimDuration | -553000 | JPY |
| Profit loss | Prior1InterimDuration | -81548000 | JPY |
| Profit loss | InterimDuration | -320059000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | － | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | － | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | -81548000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | -320059000 | JPY |
| Profit loss | Prior1InterimDuration | -81548000 | JPY |
| Profit loss | InterimDuration | -320059000 | JPY |
| Comprehensive income | Prior1InterimDuration | -81548000 | JPY |
| Comprehensive income | InterimDuration | -320059000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1InterimDuration | -81548000 | JPY |
| Comprehensive income attributable to owners of the parent | InterimDuration | -320059000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | － | JPY |
| Income before income taxes | Prior1InterimDuration | -79103000 | JPY |
| Income before income taxes | InterimDuration | -320612000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |